EUVIMEDEUVIMED entdecken
Crossref

Synthesis of Sulfonamide‐Based Schiff Bases as Potent Anticancer Agents: Spectral Analyses, Biological Activity, Molecular Docking, ADME, DFT, and Pharmacophore Modelling Studies

Eyüp Başaran iD, Reşit Çakmak iD, Burçin Türkmenoğlu iD, Senem Akkoc iD, Semiha Köprü iD

Chemistry & Biodiversity · 2025-02 · 22 (2)

DOI: 10.1002/cbdv.202402229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 09.11.2024. Verfasst von Eyüp Başaran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Batman University, Vocational School of Technical Sciences, Department of Chemistry and Chemical Processing Technologies, Batman, 72060, Türkiye. Hauptthemen laut MEDLINE: Schiff Bases, Antineoplastic Agents, Sulfonamides, Molecular Docking Simulation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Süleyman Demirel University Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study focuses on the synthesis and characterization of six benzenesulfonamide‐based Schiff base derivatives ( 7 – 12 ) with various electron‐withdrawing and electron‐donating substituents (−F, ‐CI, ‐Br, −CH 3 , and −OCH 3 ) and the assessment of their antiproliferative activities against human lung (A549) and liver (HepG2) cancer cell lines using in vitro and in silico approaches. The structures of the synthesized compounds ( 7 – 12 ) were elucidated by elemental analysis and FT‐IR, 1D ( 1 H, 13 C, APT, and DEPT‐135), and 2D (HMQC and HMBC) NMR spectroscopies. The cytotoxic activities of the targeted compounds were determined at various concentrations against these cancer cell lines for 72 h, using the MTT method. The targeted molecules ( 7 – 12 ) demonstrated remarkable antiproliferative activities, with IC 50 values ranging from 6.032–9.533 μM against the A549 cell line and 5.244–9.629 μM against the HepG2 cell line. These compounds showed activities at lower or very similar concentrations to cisplatin against the A549 cell line and at much lower concentrations than cisplatin against the HepG2 cell line. Among them, compounds 10 and 12 were found to be more effective against A549 and HepG2 cells, respectively, than cisplatin. These compounds were analyzed by interacting with the 1BNA, 4HJO, and 4ASD crystal structures in molecular docking studies. The docking score of 4ASD‐compound 12 interaction was calculated as −4.045 kcal/mol, 4HJO‐compound 10 interaction was calculated as −5.179 kcal/mol and 1BNA‐compound 10 interaction was calculated as −8.571 kcal/mol and it was determined that these compounds were theoretically better than Cisplatin. In the present study, ADME data were estimated using the web tool SwissADME. With ADME, it was calculated that the logP value of compounds 7 – 12 was less than 5, the HBD number was 1, the HBA number was 7 or 8, and the molecular weight was less than 500. Properties such as the electrophilic index and chemical hardness of the designed compounds were examined by density functional theory (DFT) using B3LYP/6‐311G**. In conclusion, these compounds have emerged as promising new anti‐cancer drug candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schiff BasesAntineoplastic AgentsSulfonamidesMolecular Docking SimulationCell ProliferationDrug Screening Assays, AntitumorDensity Functional TheoryHumansMolecular StructureStructure-Activity RelationshipDose-Response Relationship, DrugHep G2 CellsCell Line, TumorPharmacophore

Stichwörter der Autor:innen

Chemotherapeutic drug candidateSchiff base derivativeSulfonamidein silico study

Substanzen

Schiff BasesAntineoplastic AgentsSulfonamides

Autor:innen und Institutionen

  • Batman University, Vocational School of Technical Sciences, Department of Chemistry and Chemical Processing Technologies, Batman, 72060, Türkiye.
  • Batman University, Vocational School of Health Services, Medical Laboratory Techniques Program, Batman, 72060, Türkiye.
  • Erzincan Binali Yıldırım University, Faculty of Pharmacy, Department of Analytical Chemistry, Erzincan, 24002, Türkiye.
  • Suleyman Demirel University, Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Isparta, 32260, Türkiye.
  • Bahcesehir University, Faculty of Engineering and Natural Sciences, Istanbul, 34353, Türkiye.
  • Erciyes University, Department of Chemistry, Faculty of Sciences, Kayseri, 38039, Türkiye.

ORCID-Profile: Eyüp Başaran, Reşit Çakmak, Burçin Türkmenoğlu, Senem Akkoc, Semiha Köprü

Förderung

  • Süleyman Demirel University Research Fund

Zitieren

APA

Başaran, E., Çakmak, R., Türkmenoğlu, B., Akkoc, S., & Köprü, S. (2025). Synthesis of Sulfonamide‐Based Schiff Bases as Potent Anticancer Agents: Spectral Analyses, Biological Activity, Molecular Docking, ADME, DFT, and Pharmacophore Modelling Studies. Chemistry & Biodiversity, 22(2). https://doi.org/10.1002/cbdv.202402229

Vancouver

Başaran E, Çakmak R, Türkmenoğlu B, Akkoc S, Köprü S. Synthesis of Sulfonamide‐Based Schiff Bases as Potent Anticancer Agents: Spectral Analyses, Biological Activity, Molecular Docking, ADME, DFT, and Pharmacophore Modelling Studies. Chemistry & Biodiversity. 2025;22(2). doi:10.1002/cbdv.202402229

BibTeX
@article{Baaran2025,
  author = {Başaran, Eyüp and Çakmak, Reşit and Türkmenoğlu, Burçin and Akkoc, Senem and Köprü, Semiha},
  title = {Synthesis of Sulfonamide‐Based Schiff Bases as Potent Anticancer Agents: Spectral Analyses, Biological Activity, Molecular Docking, ADME, DFT, and Pharmacophore Modelling Studies},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  volume = {22},
  number = {2},
  doi = {10.1002/cbdv.202402229}
}
Kostenlos starten →